Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) EVP Steve Weinrauch sold 11,916 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $53.00, for a total transaction of $631,548.00. Following the transaction, the executive vice president now directly owns 48,978 shares of the company’s stock, valued at $2,595,834. This represents a 19.57 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Trupanion Price Performance
TRUP traded up $0.95 on Friday, reaching $53.60. The company had a trading volume of 547,598 shares, compared to its average volume of 679,874. The business has a 50 day simple moving average of $48.92 and a 200 day simple moving average of $39.04. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market cap of $2.27 billion, a price-to-earnings ratio of -165.72 and a beta of 1.69. Trupanion, Inc. has a 52-week low of $19.69 and a 52-week high of $57.90.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The business’s quarterly revenue was up 14.6% on a year-over-year basis. During the same period in the previous year, the business posted ($0.10) EPS. As a group, sell-side analysts anticipate that Trupanion, Inc. will post -0.23 EPS for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the stock. Northland Securities raised their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Bank of America increased their price target on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Stifel Nicolaus increased their target price on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research report on Monday, September 23rd. Finally, Piper Sandler upped their price objective on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Trupanion currently has a consensus rating of “Moderate Buy” and a consensus target price of $44.67.
View Our Latest Report on Trupanion
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Tesla Investors Continue to Profit From the Trump Trade
- How to Use the MarketBeat Dividend Calculator
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.